Indications for neoadjuvant radiation in esophageal adenocarcinoma: Times are changing.

JTCVS Tech

Section of Thoracic Surgery, Department of Surgery, University of Arizona, Tucson, Ariz.

Published: June 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11184586PMC
http://dx.doi.org/10.1016/j.xjtc.2024.03.009DOI Listing

Publication Analysis

Top Keywords

indications neoadjuvant
4
neoadjuvant radiation
4
radiation esophageal
4
esophageal adenocarcinoma
4
adenocarcinoma times
4
times changing
4
indications
1
radiation
1
esophageal
1
adenocarcinoma
1

Similar Publications

Article Synopsis
  • The COVID-19 pandemic overwhelmed healthcare systems, impacting the treatment of other diseases like gastric cancer.
  • A study evaluated 769 patients with gastric adenocarcinoma, comparing those treated pre-COVID to those treated during the pandemic, noting a decrease in surgical procedures and an increase in advanced disease stages among the COVID group.
  • Despite worse initial conditions, patient outcomes remained similar, with high adherence to COVID-19 protocols ensuring safe surgical practices.
View Article and Find Full Text PDF

Evaluating the predictive value of endoscopic findings for residual colorectal cancer following neoadjuvant combination immunotherapy.

World J Gastrointest Surg

January 2025

Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

Background: Endoscopy allows for the direct observation of primary tumor characteristics and responses after neoadjuvant treatment. However, reports on endoscopic evaluation following neoadjuvant immunotherapy remain limited.

Aim: To examine the predictive value of endoscopic findings of primary tumors for responses to neoadjuvant immunotherapy.

View Article and Find Full Text PDF

Predictive factors for axillary pathological complete response to neoadjuvant therapy in elderly breast cancer patients.

BMC Cancer

January 2025

Department of Breast, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute,Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.

Purpose: This study explores the predictive factors for axillary pathological complete response(apCR) during neoadjuvant therapy(NAT) for elderly breast cancer patients to supplement the indications for retaining the axilla.

Methods: Comprehensive clinical information was gathered from November 2016 to July 2023 from elderly patients with pathology-confirmed invasive breast cancer who underwent NAT and surgery in the Breast Department of Sichuan Cancer Hospital. The relationships between clinicopathological characteristics and apCR were investigated via retrospective analysis.

View Article and Find Full Text PDF

Immuno-oncology in the daily practice.

Curr Opin Oncol

January 2025

Gustave Roussy Departement Interdisciplinaire de Soins de Support aux Patients en Onco-hematologie, Villejuif, France.

Purpose Of Review: Immune checkpoint inhibitors (ICI) have become an integral part of oncology treatment. ICI currently has approval for more than thirty tumor types with proven efficacy. However, ICI can expose patients to inflammatory side effects, such as immuno-related adverse events (irAE).

View Article and Find Full Text PDF

How Can We Improve the Survival of Patients with Colorectal Liver Metastases Using Thermal Ablation?

Cancers (Basel)

January 2025

Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto 860-8555, Japan.

Thermal ablation has been widely used for patients with small colorectal liver metastases (CRLMs), even for resectable cases; however, solid evidence has been scarce. Some propensity-score matching studies using patients with balanced baseline characteristics have confirmed less invasiveness and the comparable survival benefits of thermal ablation to liver resection. A more recent pivotal randomized controlled trial comparing thermal ablation and liver resection was presented during the American Society of Clinical Oncology 2024 meeting.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!